New Regulatory Framework for Gerotherapeutics
Key Questions
What regulatory efforts are underway for gerotherapeutics?
FDA, ARPA-H, and XPRIZE are mapping a regulatory path for gerotherapeutics to support development in the longevity field.
What clinical progress has Life Biosciences made?
Life Biosciences has dosed the first human with epigenetic reprogramming therapy as part of advancing gerotherapeutic interventions.
How might GLP-1 drugs relate to longevity?
GLP-1 drugs are emerging as potential first longevity medications due to weight-independent benefits observed in research.
FDA, ARPA-H, and XPRIZE map regulatory path for gerotherapeutics. Life Biosciences doses first human for epigenetic reprogramming. GLP-1 drugs emerge as potential first longevity medications with weight-independent benefits.
Sources (2)
Updated Jul 31, 2026